Profilo
Andrew Keck is associated with Tyme Technologies, Inc. He was the President, CEO, CFO, Secretary & Treasurer of the company from 2011 to 2013.
He is the founder of Tyme Technologies, Inc. which was founded in 2011.
Precedenti posizioni note di Andrew Keck
| Società | Posizione | Fine |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Amministratore Delegato | 26/04/2013 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
- Borsa valori
- Insiders
- Andrew Keck
